**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 5307-14-2 |2-Nitro-p-phenylenediamine | 95-99 | 226-164-5 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 40
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Limited evidence of a carcinogenic effect.Possible risks of
irreversible effects.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. Effects of contact may be delayed.
Ingestion:
May cause digestive tract disturbances.
Inhalation:
May cause respiratory tract irritation. Effects of inhalation may be
delayed.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse. Remove contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Substance
is noncombustible.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Avoid runoff into storm sewers and ditches which lead to waterways.
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up or absorb material, then place into a
suitable clean, dry, closed container for disposal. Avoid generating
dusty conditions. Remove all sources of ignition. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible
substances. Keep containers tightly closed.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 5307-14-2:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: dark brown
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 137.00 - 140.00 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: insoluble
Specific Gravity/Density:
Molecular Formula: C6H7N3O2
Molecular Weight: 153.14
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 5307-14-2: ST3000000
LD50/LC50:
CAS# 5307-14-2: Oral, rat: LD50 = 2100 mg/kg.
Carcinogenicity:
2-Nitro-p-phenylenediamine -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 28A After contact with skin, wash immediately with
plenty of water.
WGK (Water Danger/Protection)
CAS# 5307-14-2: 2
Canada
CAS# 5307-14-2 is listed on Canada's DSL List.
CAS# 5307-14-2 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 5307-14-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/21/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
L-Ascorbic acid
| 50-81-7 |
|
L-Asparagine Monohydrate
| 5794-13-8 |
|
L-Tryptophan
| 73-22-3 |
|
L-Tyrosine
| 60-18-4 |
|
L-Methionine
| 63-68-3 |
|
Methyl 5-oxazolecarboxylate, 96%
| 121432-12-0 |
|
L-Histidine
| 71-00-1 |
|
L-Histidine Hydrochloride Monohydrate
| 5934-29-2 |
|
Cycloheptatriene, 90%
| 544-25-2 |
|
2-Iodobenzyl alcohol, 99%
| 5159-41-1 |
|
5-Chlorovaleryl Chloride, 96%
| 1575-61-7 |
|
2-Nitro-p-phenylenediamine, 95-99%
| 5307-14-2 |
|
1,4-Dioxaspiro[4.5]decan-8-ol, 98+%
| 22428-87-1 |
|
Pyrazino[2,3-f]Quinoxaline, 99+%
| 231-23-2 |
|
Lanthanum chloride heptahydrate
| 10025-84-0 |
|
Lanthanum Oxide
| 1312-81-8 |
|
Lanthanum Nitrate Hexahydrate
| 10099-59-9 |
|
2,3-Pentanedione, 97%
| 600-14-6 |
|
Lauric Acid
| 143-07-7 |
|
Alpha-NPO, Scintillation Grade
| 846-63-9 |
|
4-Benzylpiperidine, 98%
| 31252-42-3 |
|
2-(2-Quinoxalinyl)malondialdehyde
| 0-00-0 |
|
4-Nitro-Benzylthiocyanate, 99%
| 13287-49-5 |
|
Methyl vinyl ketone
| 78-94-4 |
|
Lead
| 7439-92-1 |
|
2-Methoxy-5-nitroaniline, 99%
| 99-59-2 |
|
Methyltriphenylphosphonium iodide, 97%
| 2065-66-9 |
|
Lead(II) acetate trihydrate
| 301-04-2 |
|
4-Ethylbiphenyl-4'-carboxylic acid, 98%
| 5731-13-5 |
|
Mono-(Trimethylsilyl)Phosphite
| 91076-68-5 |
|
N-Acetylanthranilic acid, 99%
| 89-52-1 |
|
1,2,2,6,6-Pentamethylpiperidine, 95% (GC)
| 79-55-0 |
|
Dihydrogentrifluoride Polymer-Supported, ca 7 mMol HF/g of Amberlyst
| 12260-12-7 |
|
Lead (II) Chloride
| 7758-95-4 |
|
Triisopropanolamine borate, 98+%
| 101-00-8 |
|
(S)-3-tert.-Butyl-2,5-piperazinedione
| 65016-62-8 |
|
2-Methoxynaphthalene, 98%
| 93-04-9 |
|
Lead chromate
| 7758-97-6 |
|
1-(2'-Thienyl)Ethylmercaptan, 98%
| 94089-02-8 |
|
4-Bromobenzotrifluoride, 99%
| 402-43-7 |
|
Lead Dioxide
| 1309-60-0 |
|
N-Hydroxymaleimide, 97%
| 4814-74-8 |
|
1-Dodecanethiol, 98.5+% (gc)
| 112-55-0 |
|
2,4,6-Trimethylaniline, 97%
| 88-05-1 |
|
Iodobenzene diacetate, 98%
| 3240-34-4 |
|
Trans 2, cis 6-nonadienol, 94%
| 28069-72-9 |
|
1,5-Dihydroxy-1,2,3,4-Tetrahydro-Naphthalene, Tech.
| 40771-26-4 |
|
Acrolein dimethyl acetal, 99%
| 6044-68-4 |
|
Lead(II) nitrate
| 10099-74-8 |
|
Lead Oxide Yellow
| 1317-36-8 |
|
|